These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16625482)

  • 1. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
    Neumann T; Hölschermann H
    Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
    [No Abstract]   [Full Text] [Related]  

  • 2. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone and dronedarone: the worker bee and the drone?
    Franz MR; Singh SN
    Heart Rhythm; 2010 Sep; 7(9):1280-1. PubMed ID: 20620232
    [No Abstract]   [Full Text] [Related]  

  • 5. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class 1 antiarrhythmic agents for therapy of atrial fibrillation.
    Podrid PJ
    Herz; 1993 Feb; 18(1):9-19. PubMed ID: 8454255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone and atrial fibrillation.
    London B
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1321-2. PubMed ID: 17971150
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug treatment of atrial fibrillation].
    Janko S; Hoffmann E
    MMW Fortschr Med; 2006 Apr; 148(15):32-5. PubMed ID: 16711199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.
    Shinagawa K; Derakhchan K; Nattel S
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):752-64. PubMed ID: 12698678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
    Casaclang-Verzosa G; Gersh BJ; Tsang TS
    J Am Coll Cardiol; 2008 Jan; 51(1):1-11. PubMed ID: 18174029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhythm control for atrial fibrillation: non-channel antiarrhythmic drugs are en vogue.
    Van Gelder IC
    Cardiovasc Res; 2007 Apr; 74(1):8-10. PubMed ID: 17336952
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant therapy for atrial fibrillation.
    Mohammed KS; Kowey PR; Musco S
    Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of atrial fibrillation and flutter].
    Fazekas T
    Orv Hetil; 2003 Aug; 144(34):1687-9. PubMed ID: 14528843
    [No Abstract]   [Full Text] [Related]  

  • 15. [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].
    Ravens U; Wettwer E; Schotten U; Wessel R; Dobrev D
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):64-72. PubMed ID: 16786464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.
    Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ
    Cardiol Rev; 2007; 15(5):231-41. PubMed ID: 17700382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upstream effect for atrial fibrillation: still a dilemma?
    Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of atrial fibrillation: future directions.
    Page RL
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S91-4. PubMed ID: 17336894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling).
    Goette A; Bukowska A; Lendeckel U
    Curr Opin Pharmacol; 2007 Apr; 7(2):219-24. PubMed ID: 17276728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.